2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$5.86-$0.49 (-7.70%)
Price as of Jun 03, 2026 6:20 PM EDT- $1.1BMarket Cap
- 128.42%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$5.86-$0.49 (-7.70%)
ABSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.35 | ||
Change | -$0.17 (-2.61%) | ||
Open | $6.48 | ||
High | $6.55 | ||
Low | $6.13 | ||
Previous Close | $6.52 | ||
Volume | 3,693,800 | ||
30-Day Average Volume | 4,959,898 | ||
1-Week Change | 20.27% | ||
1-Month Change | 29.07% | ||
1-Year Change | 128.42% | ||
3-Year Change | 237.77% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 155.9M | ||
Total Assets | $195.6M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $215,000.00 | ||
Net Income | -$29.6M | ||
Free Cash Flow | -$26.3M | ||
EBIT | -$29.6M | ||
EBITDA | -$26.9M | ||
Net Working Capital | $111.9M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | 4,856 | ||
P/B | 6 | ||
P/E | -36 | ||
PEG | -12 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue